Endurance Wealth Management, Inc. Aerie Pharmaceuticals Inc Transaction History

Endurance Wealth Management, Inc.

$731 Million
Q2 2023

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 21, 2022	SELL	$6.37 - $15.23 $49,686 - $118,794	-7,800 Reduced 4.66%	159,703 $2.42 Million
Q2 2022 Jul 20, 2022	SELL	$4.95 - $9.16 $24,750 - $45,800	-5,000 Reduced 2.9%	167,503 $1.26 Million
Q1 2022 Apr 20, 2022	BUY	$5.64 - $9.8 $80,843 - $140,473	14,334 Added 9.06%	172,503 $1.57 Million
Q4 2021 Jan 19, 2022	SELL	$7.02 - $13.33 $329,245 - $625,190	-46,901 Reduced 22.87%	158,169 $1.11 Million
Q3 2021 Oct 28, 2021	BUY	$11.32 - $16.63 $312,556 - $459,170	27,611 Added 15.56%	205,070 $2.34 Million
Q2 2021 Aug 04, 2021	BUY	$15.16 - $18.97 $755,862 - $945,825	49,859 Added 39.07%	177,459 $2.84 Million
Q1 2021 May 05, 2021	BUY	$13.12 - $20.9 $369,459 - $588,544	28,160 Added 28.32%	127,600 $2.28 Million
Q4 2020 Jan 15, 2021	BUY	$9.12 - $14.49 $885,460 - $1.41 Million	97,090 Added 4131.49%	99,440 $1.34 Million
Q3 2020 Oct 27, 2020	SELL	$10.46 - $14.46 $2,092 - $2,892	-200 Reduced 7.84%	2,350 $28,000
Q2 2020 Jul 14, 2020	SELL	$12.0 - $16.13 $6,000 - $8,064	-500 Reduced 16.39%	2,550 $37,000
Q1 2020 May 11, 2020	BUY	$11.84 - $25.52 $8,880 - $19,140	750 Added 32.61%	3,050 $41,000
Q4 2019 Jan 14, 2020	SELL	$17.72 - $25.1 $5,316 - $7,530	-300 Reduced 11.54%	2,300 $55,000
Q3 2019 Oct 18, 2019	BUY	$18.41 - $28.0 $30,376 - $46,200	1,650 Added 173.68%	2,600 $50,000
Q2 2019 Jul 30, 2019	BUY	$28.97 - $48.21 $13,036 - $21,694	450 Added 90.0%	950 $28,000
Q4 2018 Jan 14, 2019	BUY	$33.0 - $60.04 $6,600 - $12,008	200 Added 66.67%	500 $18,000
Q1 2018 Apr 19, 2018	BUY	$51.15 - $61.0 $5,115 - $6,100	100 Added 50.0%	300 $16,000
Q3 2017 Oct 19, 2017	BUY	$48.6 - $60.1 $9,720 - $12,020	200	200 $10,000

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurance Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Endurance Wealth Management, Inc. with notifications on news.

Account